A detailed history of American Research & Management Co. transactions in Viatris Inc stock. As of the latest transaction made, American Research & Management Co. holds 284 shares of VTRS stock, worth $3,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
284
Previous 297 4.38%
Holding current value
$3,575
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 07, 2022

SELL
$8.48 - $11.13 $110 - $144
-13 Reduced 4.38%
284 $2,000
Q1 2022

Apr 21, 2022

SELL
$9.81 - $15.4 $1,667 - $2,618
-170 Reduced 36.4%
297 $3,000
Q4 2021

Jan 28, 2022

BUY
$12.09 - $14.68 $749 - $910
62 Added 15.31%
467 $6,000
Q2 2021

Jul 16, 2021

SELL
$12.97 - $16.15 $1,335 - $1,663
-103 Reduced 20.28%
405 $6,000
Q1 2021

Apr 06, 2021

SELL
$13.59 - $18.54 $54,890 - $74,883
-4,039 Reduced 88.83%
508 $7,000
Q4 2020

Jan 28, 2021

BUY
$14.3 - $18.74 $65,022 - $85,210
4,547 New
4,547 $85,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track American Research & Management Co. Portfolio

Follow American Research & Management Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.